Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432830 · ClinicalTrials.gov registry record · NA
Sex Differences in E-cig Perception: Study 1
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT05432830 is a NA study that has completed, run by Yale University. The registered enrollment target is 66 participants.
The verdict
NCT05432830, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The primary objective is to examine the influence of sex on sensory effects, appeal, and reinforcing value of nicotine containing e-cigs in popular flavor components; sweet and cooling.
Interventions
- OTHER E-liquid Flavor 1
- OTHER E-liquid Flavor 2
- OTHER E-liquid Flavor 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2025-07-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05432830
The ClinicalTrials.gov registry entry for NCT05432830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which E-liquid Flavor 1 is the first listed.
NCT05432830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05432830 about?
NCT05432830 is a clinical study titled "Sex Differences in E-cig Perception: Study 1". The primary objective is to examine the influence of sex on sensory effects, appeal, and reinforcing value of nicotine containing e-cigs in popular flavor components; sweet and cooling.
What is the current status of trial NCT05432830?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2024-04-30. Estimated completion is 2025-07-18.
What interventions are being tested in trial NCT05432830?
The interventions under investigation include: E-liquid Flavor 1 (OTHER), E-liquid Flavor 2 (OTHER), E-liquid Flavor 3 (OTHER).
Who is sponsoring clinical trial NCT05432830?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.